Evidence map›Paper›PMID 39728827›Full record

ArticleTropical medicine and infectious disease2024

Snakebites in Cameroon by Species Whose Effects Are Poorly Described.

Jean-Philippe Chippaux, Yoann Madec, Pierre Amta, Rodrigue Ntone, Gaëlle Noël, Pedro Clauteaux, Yap Boum, Armand S Nkwescheu, Fabien Taieb

Abstract read
In one paragraph

Article in Tropical medicine and infectious disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jean-Philippe ChippauxMERIT Unit, Institut de Recherche pour le Développement, Paris Cité University, F-75006 Paris, France.ORCID 0000-0002-1976-8568
Yoann MadecEmerging Diseases Epidemiology Unit, Institut Pasteur, Paris Cité University, F-75015 Paris, France.ORCID 0000-0002-6201-1261
Pierre AmtaTokombere Hospital, Mora P.O. Box 74, Cameroon.
Rodrigue NtoneEpicentre Yaounde, Yaounde P.O. Box 12069, Cameroon.
Gaëlle NoëlInstitut Pasteur, Translational Research Center, Paris Cité University, F-75015 Paris, France.
Pedro ClauteauxInstitut Pasteur, Translational Research Center, Paris Cité University, F-75015 Paris, France.
Yap BoumInstitut Pasteur de Bangui, Bangui P.O. Box 923, Central African Republic.
Armand S NkwescheuCameroon Society of Epidemiology, Yaounde P.O. Box 1411, Cameroon.
Fabien TaiebInstitut Pasteur Medical Center, Paris Cité University, F-75015 Paris, France.ORCID 0000-0002-0941-2859

Funding

Institut Pasteur Paris 2016-092 ESAA
6 · The paper itself

Abstract

Snakes responsible for bites are rarely identified, resulting in a loss of information about snakebites from venomous species whose venom effects are poorly understood. A prospective clinical study including patients bitten by a snake was conducted in Cameroon between 2019 and 2021 to evaluate the efficacy and tolerability of a marketed polyvalent antivenom. Clinical presentation during the first 3 days of hospitalization was recorded following a standardized protocol. This ancillary study aimed to assess the frequency of bites by the different species encountered in Cameroon and to describe the symptoms of bites by formally identified species. Of the 447 patients included in the study, 159 (35.6%) brought the snake that caused the bite that was identified by a specialist. Out of these, 8 specimens could not be identified due to poor condition, 19 were non-venomous species, and 95 belonged to

Indexed as

antivenomelapidenvenomationsnakebitesub-Saharan Africaviper

Identifiers

PMID39728827
PMCPMC11679889

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.